Stratos Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Stratos Wealth Advisors's GILD Position: Q2 2026 in Review
Stratos Wealth Advisors increased its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, buying an estimated $8.83K and bringing the position to 1,683 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #600.
Stratos Wealth Advisors first reported a position in GILD in Q4 2018 and has held it in 20 quarters since. The position peaked at $667K in Q2 2021. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Stratos Wealth Advisors held 1,683 shares of Gilead Sciences worth $213K as of Q2 2026.
- Stratos Wealth Advisors bought 67 Gilead Sciences shares in Q2 2026, an estimated $8.83K.
- Gilead Sciences made up 0.01% of Stratos Wealth Advisors's portfolio in Q2 2026, its #600 holding.
- Stratos Wealth Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 20 quarters since.
- Stratos Wealth Advisors's Gilead Sciences position peaked at $667K in Q2 2021.
- 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Stratos Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.